The CDH1 gene, also known as E-cadherin, plays a crucial role in cell adhesion, influencing cellular processes and maintaining the integrity of epithelial layers in the body. Mutations in the CDH1 gene are strongly associated with an increased risk of developing hereditary diffuse gastric cancer (HDGC), a rare but aggressive form of stomach cancer characterized by the widespread infiltration of cancer cells throughout the stomach lining. These mutations can also increase the risk of other cancers, including lobular breast cancer.
Recognizing the genetic link to this condition, the CDH1 Gene Gastric Cancer Hereditary Diffuse Genetic Test is a specialized diagnostic tool designed to identify mutations in the CDH1 gene. This test is crucial for individuals with a family history of diffuse gastric cancer or those who meet specific clinical criteria suggesting a high risk of HDGC. Early identification of CDH1 mutations can enable at-risk individuals to make informed decisions about their health, including taking preventive measures such as increased surveillance or considering prophylactic surgery to reduce cancer risk.
DNA Labs UAE offers this genetic testing service, providing a thorough analysis of the CDH1 gene to detect any mutations. The test is priced at 4400 AED and is conducted in their state-of-the-art facilities, ensuring high accuracy and reliability. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic predisposition to hereditary diffuse gastric cancer, allowing them to take proactive steps towards managing their health and potentially preventing the onset of this challenging disease.
The "KIT Gene Gastrointestinal Stromal Tumor Familial Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the KIT gene, which are strongly associated with the development of Gastrointestinal Stromal Tumors (GISTs). This type of tumor is relatively rare and occurs primarily in the digestive tract, with the stomach and small intestine being the most common locations. The KIT gene plays a crucial role in cell growth and division; mutations in this gene can lead to uncontrolled cell proliferation, resulting in GISTs.
This genetic test is particularly important for individuals with a family history of GISTs, as it can help in early detection and management of the condition. By analyzing a person's DNA, the test can identify specific mutations in the KIT gene that are known to increase the risk of developing GISTs. This information is invaluable for both patients and healthcare providers, as it can guide decisions regarding monitoring, preventive measures, and treatment options tailored to the genetic profile of the individual.
The test is offered by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. DNA Labs UAE is equipped with state-of-the-art facilities and employs highly skilled professionals to ensure accurate and reliable test results. For families affected by GISTs, this test represents a critical tool in managing and potentially mitigating the impact of this condition.
The CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the CDKN1C gene, which are associated with Beckwith-Wiedemann Syndrome (BWS). Beckwith-Wiedemann Syndrome is a congenital overgrowth disorder that affects various parts of the body and increases the risk of developing certain types of tumors. This genetic test plays a crucial role in the early detection and management of BWS, enabling healthcare providers to implement appropriate surveillance and treatment strategies for affected individuals. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. Through this test, families can gain valuable insights into the genetic basis of BWS, facilitating informed decisions regarding healthcare and family planning.
The Chr. 11p15 Gene Beckwith-Wiedemann Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the chromosome 11p15 region, which are associated with Beckwith-Wiedemann Syndrome (BWS). BWS is a congenital overgrowth disorder that can lead to an increased risk of childhood cancer and various other abnormalities, including macroglossia (enlarged tongue), abdominal wall defects, and hemihypertrophy (asymmetrical body growth).
This genetic test is crucial for early detection and management of BWS, as it allows for personalized monitoring and treatment plans to be developed, reducing the risk of complications associated with the syndrome. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the 11p15 region that are indicative of BWS.
The cost of the Chr. 11p15 Gene Beckwith-Wiedemann Syndrome Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specialized nature of this test, it represents a significant step forward in the personalized care and management of individuals with Beckwith-Wiedemann Syndrome, offering families the information necessary to make informed health and treatment decisions.
The H19 Gene Beckwith-Wiedemann Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the H19 gene associated with Beckwith-Wiedemann Syndrome (BWS). BWS is a genetic disorder characterized by overgrowth and an increased risk of developing childhood tumors. The condition can lead to various clinical manifestations, including macroglossia, abdominal wall defects, and hemihyperplasia.
The test is conducted through a comprehensive analysis of the patient's DNA to identify any genetic alterations in the H19 gene that may indicate the presence of Beckwith-Wiedemann Syndrome. This early detection is crucial for managing the condition, allowing for appropriate medical interventions and monitoring to mitigate the risks associated with the syndrome.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test is performed by experienced geneticists and laboratory technicians using state-of-the-art technology to ensure accurate and reliable results. Patients opting for this test at DNA Labs UAE can expect a professional and supportive environment, with guidance provided throughout the testing process.
The KCNQ1OT1 Gene Beckwith-Wiedemann Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the KCNQ1OT1 gene, which are associated with Beckwith-Wiedemann Syndrome (BWS). Beckwith-Wiedemann Syndrome is a genetic disorder characterized by overgrowth and an increased risk of developing childhood tumors. The condition exhibits a range of symptoms, including macroglossia (enlarged tongue), abdominal wall defects, and asymmetrical body growth.
This genetic test plays a crucial role in the early identification and management of BWS, facilitating personalized treatment plans and surveillance for associated complications. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and reliability. The cost of the KCNQ1OT1 Gene Beckwith-Wiedemann Syndrome Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise involved in detecting the specific gene mutations responsible for the syndrome. By opting for this test, individuals at risk can gain valuable insights into their genetic makeup, empowering them with the knowledge to make informed health decisions.
The BRAF gene is an important piece of the puzzle in understanding various types of cancer. It encodes a protein called B-Raf, which plays a critical role in regulating cell growth. Mutations in the BRAF gene, particularly in exon 15, are associated with several types of cancer, including melanoma, colorectal cancer, and thyroid cancer. These mutations lead to abnormal cell growth and cancer development.
The BRAF Selective Sequencing of Exon 15 Genetic Test is a specialized diagnostic tool used to identify mutations in exon 15 of the BRAF gene. This test is crucial for patients suspected of having cancers that are known to be associated with BRAF mutations. By identifying the presence of these mutations, healthcare providers can make more informed decisions regarding the patient's treatment options, as certain therapies are specifically designed to target cancers with BRAF mutations.
The test is available at DNA Labs UAE, a leading facility for genetic testing in the United Arab Emirates. The cost of the BRAF Selective Sequencing of Exon 15 Genetic Test is 4400 AED. This price reflects the specialized nature of the test and the valuable insights it provides for personalized cancer treatment plans. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable test results for patients and their healthcare providers.
The RINT1 gene plays a crucial role in cellular processes such as the maintenance of the Golgi apparatus and DNA damage response. Mutations in the RINT1 gene have been associated with an increased risk of developing breast cancer, among other cancers. Recognizing the significance of this gene in the context of breast cancer can aid in early detection and personalized treatment plans for individuals at risk.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the RINT1 gene. This test is particularly valuable for individuals with a family history of breast cancer or those who have been identified as having a higher risk of developing this type of cancer. By analyzing a sample of the individual's DNA, the test can pinpoint specific mutations in the RINT1 gene that may contribute to the development of breast cancer.
The cost of the RINT1-related genetic test at DNA Labs UAE is 4400 AED. This investment can provide crucial information for individuals and their healthcare providers, enabling them to make informed decisions about surveillance, preventive measures, or treatment options tailored to the genetic makeup of the individual. Early detection and personalized approaches to cancer management have been shown to improve outcomes, making this test a valuable tool in the fight against breast cancer.
The BARD1 gene plays a critical role in DNA repair mechanisms, and mutations in this gene have been associated with an increased susceptibility to breast cancer. Recognizing the significance of early detection and intervention, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the BARD1 gene. This test is a crucial tool for individuals with a family history of breast cancer or those deemed at high risk, providing them with the opportunity to take proactive measures in managing their health.
The testing process involves a simple sample collection, followed by comprehensive analysis to detect any genetic abnormalities linked to breast cancer susceptibility. With a cost of 4400 AED, the test represents a valuable investment in personal health, offering insights that could lead to early detection and more effective management of breast cancer risk. Conducted in the state-of-the-art facilities of DNA Labs UAE, clients are assured of accurate, reliable results and the support of expert genetic counselors to interpret their findings and guide them through their next steps.
The PALB2 gene, which stands for Partner and Localizer of BRCA2, plays a critical role in DNA repair mechanisms that maintain the integrity of our genetic material. Mutations in the PALB2 gene have been linked to an increased risk of developing breast cancer, making it a significant marker for assessing breast cancer susceptibility. Genetic testing for PALB2 mutations provides valuable information for individuals concerned about their risk of developing breast cancer, allowing for personalized risk management and preventive strategies.
DNA Labs UAE offers a comprehensive genetic test for the PALB2 gene to evaluate an individual's susceptibility to breast cancer. The test is priced at 4400 AED and involves a simple, non-invasive procedure that can be crucial for those with a family history of breast cancer or other related cancers. By identifying mutations in the PALB2 gene, DNA Labs UAE provides essential insights into an individual's cancer risk, empowering them with the knowledge to take proactive steps towards their health, including enhanced surveillance, lifestyle changes, or preventive treatments. This genetic test is a vital tool in the fight against breast cancer, offering hope and options for those at increased risk.
